跳至主要内容
临床试验/ACTRN12621001499875
ACTRN12621001499875招募中2 期

A randomized feasibility study comparing dexmedetomidine with standard of care drug therapy in the management of agitation patients with a palliative diagnosis in a hospice setting.

Dr Lana Ferguson0 个研究点目标入组 20 人开始时间: 2021年11月4日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Palliative diagnosis with a prognosis of 6 months or less;
  • Patient has agitation requiring pharmacological management (RASS-PAL greater than or equal to +2);
  • 18 years and over.

排除标准

  • Patients with known AV block in the absence of functioning pacemaker;
  • Bradycardia (baseline heart rate less than 55 beats per minute);
  • Patients with end-stage heart failure with documented ejection fraction <20%;
  • Hypotension (systolic blood pressure < 90mmHg);
  • Patients with a chronic mental health history who are taking long-term antipsychotic medication.
  • Non-English speaking

研究者

发起方
Dr Lana Ferguson

相似试验